An Overview on Human Umbilical Cord Blood Stem Cell-Based Alternative In Vitro Models for Developmental Neurotoxicity Assessment

被引:0
|
作者
Abhishek Kumar Singh
Mahendra Pratap Kashyap
机构
[1] National Institute of Technology,Department of Biotechnology and Medical Engineering
[2] University of Pittsburgh School of Medicine,Department of Urology
来源
Molecular Neurobiology | 2016年 / 53卷
关键词
Umbilical cord blood stem cells; Haematopoietic stem cells; Neuronal differentiation; Developmental neurotoxicity; models for DNTs;
D O I
暂无
中图分类号
学科分类号
摘要
The developing brain is found highly vulnerable towards the exposure of different environmental chemicals/drugs, even at concentrations, those are generally considered safe in mature brain. The brain development is a very complex phenomenon which involves several processes running in parallel such as cell proliferation, migration, differentiation, maturation and synaptogenesis. If any step of these cellular processes hampered due to exposure of any xenobiotic/drug, there is almost no chance of recovery which could finally result in a life-long disability. Therefore, the developmental neurotoxicity (DNT) assessment of newly discovered drugs/molecules is a very serious concern among the neurologists. Animal-based DNT models have their own limitations such as ethical concerns and lower sensitivity with less predictive values in humans. Furthermore, non-availability of human foetal brain tissues/cells makes job more difficult to understand about mechanisms involve in DNT in human beings. Although, the use of cell culture have been proven as a powerful tool for DNT assessment, but many in vitro models are currently utilizing genetically unstable cell lines. The interpretation of data generated using such terminally differentiated cells is hard to extrapolate with in vivo situations. However, human umbilical cord blood stem cells (hUCBSCs) have been proposed as an excellent tool for alternative DNT testing because neuronal development from undifferentiated state could exactly mimic the original pattern of neuronal development in foetus when hUCBSCs differentiated into neuronal cells. Additionally, less ethical concern, easy availability and high plasticity make them an attractive source for establishing in vitro model of DNT assessment. In this review, we are focusing towards recent advancements on hUCBSCs-based in vitro model to understand DNTs.
引用
收藏
页码:3216 / 3226
页数:10
相关论文
共 50 条
  • [41] Human umbilical cord blood derived mesenchymal stem cell has a powerful cardiomyogenic potential in vitro; A novel cell source for cardiac stem cell based therapy
    Nishiyama, N
    Miyoshi, S
    Okamoto, K
    Hida, N
    Kegami, Y
    Uyama, T
    Miyado, K
    Yozu, R
    Sakamoto, M
    Ogawa, S
    Umezawa, A
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 44A - 44A
  • [42] Commentary on human pluripotent stem cell-based blood-brain barrier models
    Lippmann, Ethan S.
    Azarin, Samira M.
    Palecek, Sean P.
    Shusta, Eric V.
    FLUIDS AND BARRIERS OF THE CNS, 2020, 17 (01)
  • [43] Stem Cell-Based Embryo Models Add a Dimension to Developmental Biology
    Bradford, Shelby
    SCIENTIST, 2024, 38 (03): : 48 - 53
  • [44] A human pluripotent carcinoma stem cell-based model for in vitro developmental neurotoxicity testing: Effects of methylmercury, lead and aluminum evaluated by gene expression studies
    Laurenza, Incoronata
    Pallocca, Giorgia
    Mennecozzi, Milena
    Scelfo, Bibiana
    Pamies, David
    Bal-Price, Anna
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2013, 31 (07) : 679 - 691
  • [45] Correction to: Differentiating neurons derived fromhuman umbilical cord blood stem cells work as a test system for developmental neurotoxicity
    Mahendra P. Kashyap
    Vivek Kumar
    Abhishek K. Singh
    Vinay K. Tripathi
    Sadaf Jahan
    Ankita Pandey
    Ritesh K. Srivastava
    Vinay K. Khanna
    Aditya B. Pant
    Molecular Neurobiology, 2019, 56 : 6663 - 6663
  • [46] Umbilical Cord Mesenchymal Stem Cells: The New Gold Standard for Mesenchymal Stem Cell-Based Therapies?
    El Omar, Reine
    Beroud, Jacqueline
    Stoltz, Jean-Francois
    Menu, Patrick
    Velot, Emilie
    Decot, Veronique
    TISSUE ENGINEERING PART B-REVIEWS, 2014, 20 (05) : 523 - 544
  • [47] In vitro labeling and MRI of mesenchymal stem cells from human umbilical cord blood
    Ju, Shenghong
    Teng, Gaojun
    Zhang, Yu
    Ma, Ming
    Chen, Feng
    Ni, Yicheng
    MAGNETIC RESONANCE IMAGING, 2006, 24 (05) : 611 - 617
  • [48] Current Availability of Stem Cell-Based In Vitro Methods for Developmental Neurotoxicity (DNT) Testing (vol 165, pg 21, 2018)
    Fritsche, Ellen
    Barenys, Marta
    Klose, Jordis
    Masjosthusmann, Stefan
    Nimtz, Laura
    Schmuck, Martin
    Wuttke, Saskia
    Tigges, Julia
    TOXICOLOGICAL SCIENCES, 2018, 165 (02) : 531 - 531
  • [49] Treatment of spinal injury by human umbilical cord blood stem cell transplantation
    Han, ZC
    Zhao, Z
    Li, H
    Liu, H
    Yang, R
    EXPERIMENTAL HEMATOLOGY, 2002, 30 (06) : 139 - 139
  • [50] Human Umbilical Cord Blood as an Emerging Stem Cell Therapy for Diabetes Mellitus
    Reddi, Alluru S.
    Kuppasani, Kishore
    Ende, Norman
    CURRENT STEM CELL RESEARCH & THERAPY, 2010, 5 (04) : 356 - 361